Coming December: ASH publishes its late-breaking abstracts. We’ll add the organizations presenting them.

Electra Therapeutics at ASH 2026

Dec 12–15, 2026 New Orleans, LA ~30k attendees Website

Electra Therapeutics brings 1 presentation to ASH 2026 in New Orleans, and exhibits at Booth 2357. Its research centres on secondary hemophagocytic lymphohistiocytosis. It covers national claims data on associated conditions, treatments and care patterns.

OrganizationASH 2026 Attendance
Electra Therapeutics
South San Francisco, CA
Biotech
Clinical-stage biotech developing antibody therapies, led by ELA026, for immune and blood disorders such as hemophagocytic lymphohistiocytosis (HLH).
Booth
Exhibiting at Booth 2357
Sat, Dec 1211:00am–5:00pmSun, Dec 1310:00am–5:00pmMon, Dec 1410:00am–2:00pm

Explore the full ASH 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in New Orleans. Leave your work email and we’ll be in touch.

Privacy

Download the full ASH 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Electra Therapeutics

Tell us what you sell and we’ll find the people at Electra Therapeutics most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the American Society of Hematology (ASH). Submit a correction